Cytokinetics (CYTK) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Cytokinetics (CYTK) over the last 9 years, with Q1 2024 value amounting to $2000.0.
- Cytokinetics' Other Non-Current Liabilities fell 9976.11% to $2000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $2000.0, marking a year-over-year decrease of 9976.11%. This contributed to the annual value of $186000.0 for FY2023, which is 8218.39% down from last year.
- As of Q1 2024, Cytokinetics' Other Non-Current Liabilities stood at $2000.0, which was down 9976.11% from $186000.0 recorded in Q4 2023.
- In the past 5 years, Cytokinetics' Other Non-Current Liabilities registered a high of $174.8 million during Q3 2021, and its lowest value of $2000.0 during Q1 2024.
- Over the past 5 years, Cytokinetics' median Other Non-Current Liabilities value was $2.3 million (recorded in 2022), while the average stood at $62.1 million.
- Per our database at Business Quant, Cytokinetics' Other Non-Current Liabilities soared by 1702.56% in 2020 and then tumbled by 9976.11% in 2024.
- Over the past 5 years, Cytokinetics' Other Non-Current Liabilities (Quarter) stood at $160.4 million in 2020, then tumbled by 97.22% to $4.5 million in 2021, then crashed by 76.58% to $1.0 million in 2022, then crashed by 82.18% to $186000.0 in 2023, then plummeted by 98.92% to $2000.0 in 2024.
- Its Other Non-Current Liabilities was $2000.0 in Q1 2024, compared to $186000.0 in Q4 2023 and $408000.0 in Q3 2023.